DUBLIN, January 8, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ldm34m/collaboration) has announced the addition of the "Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769)
In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships.
Market segments such as personalized medicine, combination devices and regenerative medicine, have been the beneficiary of research and business collaborations. This research service identifies areas along the product development cycle that can be mined for collaborations, case studies of successful partnerships from the last few years, and various avenues available for stakeholders.
Key Topics Covered:
Benefits of this Report:
Report Structure:
1. Executive Summary
2. Industry Overview
3. A Compilation of Notable Collaborations
4. Different Approaches to Collaboration
5. Assessment of Investment Ecosystem
6. Avenues Open for Collaborations
7. The Last Word
For more information visit http://www.researchandmarkets.com/research/ldm34m/collaboration
About Research and Markets:
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net
Share this article